“We are proud to be the only company that can offer quantitative magnetic resonance (MR) imaging software that answers the most frequently asked question in neuro oncology today: "is the enhancing region tumor or is it treatment effect?". Our pipeline is healthy, with two additional National Cancer Institute (NCI) designated cancer centers undergoing trial evaluations of IB Clinic.”
“I want to emphasize we are the only dynamic susceptibility contrast (DSC) MR perfusion platform that generates quantitative parameter maps and the only platform validated with actual tissue biopsy samples. Our software has been repeatedly proven to accurately distinguish between tumor and non-tumor tissue - a basic yet critical question challenging treatment teams each day.”
Welcome. Not invested as yet. Re publicly traded quantum stocks it's very early in the market but here goes:
- IonQ - ion trap quantum computing (trading as a spac) - Arqit - quantum comms - Archer Materials - hybrid company based in Austria manufacturing some chips - Quantum Computing Inc - quantum software company
Saw 2 of these today sent as RNS announcements at 1.50pm and 1.53pm. Couldn't decipher if they were buys or sells. It doesn't say on the TR1 form. Assuming they were both buys as the IME share price went up 10% afterwards.
Can a TR1 be either a large buy or a large sell. Or would a sell be sent as an RNS titled 'Director Declaration' or something else.
Depends on the outcome. Lots of speculation being batted around from £10M - £30M. Could be pie in the sky. It's an Italian case so progress has been notoriously slow.
Thanks all. Just trying to establish if it was solely HL that froze us out from buying HE1 between 8.00am and 8.05am. Sounds like it was right across the board. Was disappointing and frustrating as the price looked like it was below 6p. Couldn't have pressed 'get quote' any faster or any more times.